This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Crossject. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: The Innovative Contributions of Guy Delannoy
Introduction
Guy Delannoy is a notable inventor based in Saint Medard en Jalles, France. He has made significant contributions to the field of medical technology, particularly in the development of needleless syringes. With a total of 3 patents to his name, Delannoy's work showcases his commitment to innovation and improving healthcare delivery.
Latest Patents
Delannoy's latest patents include groundbreaking designs for needleless syringes that utilize a shocktube effect. One of his inventions features a needleless syringe that comprises a gas generator, a gas expansion chamber, a means for retaining particles of the active agent, and a tube for ejecting said particles. The innovative aspect of this syringe lies in its pyrotechnic gas generator, which produces gas to propel the active agent without the need for a needle. Another patent focuses on a needleless syringe that houses particles outside the ejection tube conduit, allowing gases to displace a plunger and accelerate the particles through the tube.
Career Highlights
Delannoy is currently associated with Crossject, a company that specializes in developing innovative medical devices. His work at Crossject has allowed him to push the boundaries of traditional syringe technology, making significant strides in patient safety and comfort.
Collaborations
Throughout his career, Delannoy has collaborated with talented individuals such as Patrick Alexandre and Philippe Gautier. These partnerships have contributed to the advancement of his inventions and the overall success of his projects.
Conclusion
Guy Delannoy's contributions to the field of medical technology, particularly through his innovative needleless syringes, highlight his role as a forward-thinking inventor. His patents reflect a dedication to enhancing healthcare solutions and improving patient experiences.